## NICHOLAS MITSIADES, M.D.

| | Title| Adjunct Associate Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| One Baylor Plaza #100  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=O6Ik8mzGJI7VRIzgrn7GPw%3d%3d&rnd=2ab4964e-0083-4554-8343-0ef0b5402dc5)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=266621)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Research  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
research activities and funding

U54CA233223 (MITSIADES, NICHOLAS)Sep 20, 2018 - Jun 30, 2023NIH  
Minority PDX Development and Trial Center: Baylor College of Medicine and MD
Anderson Cancer Center Collaboration on Mechanistic Studies to Dissect and
Combat Health Disparities in Cancer  
Role: Principal Investigator  
---  
  
* * *  
  
R01CA193321 (MITSIADES, NICHOLAS)Aug 1, 2015 - Jul 31, 2020NIH  
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF  
Role: Principal Investigator  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Berchuck JE, Adib E, Abou Alaiwi S, Dash AK, Shin JN, [Lowder D](https://profiles.viictr.org/profile/28999351), [McColl C](https://profiles.viictr.org/profile/28999350), [Castro P](https://profiles.viictr.org/profile/268709), Carelli R, Benedetti E, Deng J, Robertson M, Baca SC, Bell C, McClure HM, El Zarif T, Davidsohn MP, Lakshminarayanan G, [Rizwan K](https://profiles.viictr.org/profile/31168783), Skapura DG, [Grimm SL](https://profiles.viictr.org/profile/35589914), Davis CM, Ehli EA, Kelleher KM, Seo JH, Mitsiades N, [Coarfa C](https://profiles.viictr.org/profile/265668), Pomerantz MM, Loda M, [Ittmann M](https://profiles.viictr.org/profile/269566), Freedman ML, Kaochar S. The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response. Cancer Res. 2022 08 16; 82(16):2848-2859. PMID: [35731919](//www.ncbi.nlm.nih.gov/pubmed/35731919); PMCID: [PMC9379363](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9379363).

Citations:  Fields:

Neo Neoplasms

  2. Koc S, Lloyd MW, Grover JW, Xiao N, Seepo S, Subramanian SL, Ray M, Frech C, DiGiovanna J, Webster P, Neuhauser S, Srivastava A, Woo XY, Sanderson BJ, White B, Lott P, Dobrolecki LE, Dowst H, PDXNet Consortium , Evrard YA, Wallace TA, Moscow JA, Doroshow JH, Mitsiades N, Kaochar S, Pan CX, Chen MS, Carvajal-Carmona L, Welm AL, Welm BE, [Lewis MT](https://profiles.viictr.org/profile/267000), Govindan R, Ding L, Li S, Herlyn M, Davies MA, [Roth J](https://profiles.viictr.org/profile/12583652), [Meric-Bernstam F](https://profiles.viictr.org/profile/12583329), Robinson PN, Bult CJ, Davis-Dusenbery B, Dean DA, Chuang JH. PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery. NAR Cancer. 2022 Jun; 4(2):zcac014. PMID: [35475145](//www.ncbi.nlm.nih.gov/pubmed/35475145); PMCID: [PMC9026194](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9026194).

Citations:

  3. [Lowder D](https://profiles.viictr.org/profile/28999351), [Rizwan K](https://profiles.viictr.org/profile/31168783), [McColl C](https://profiles.viictr.org/profile/28999350), [Paparella A](https://profiles.viictr.org/profile/31189480), [Ittmann M](https://profiles.viictr.org/profile/269566), Mitsiades N, Kaochar S. Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics. Cancer Lett. 2022 04 10; 531:71-82. PMID: [35122875](//www.ncbi.nlm.nih.gov/pubmed/35122875); PMCID: [PMC9701576](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9701576).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  4. Kaochar S, Rusin A, Foley C, Rajapakshe K, Robertson M, Skapura D, Mason C, Berman De Ruiz K, Tyryshkin AM, Deng J, Shin JN, [Fiskus W](https://profiles.viictr.org/profile/17440164), Dong J, Huang S, [Navone NM](https://profiles.viictr.org/profile/12583292), Davis CM, Ehli EA, [Coarfa C](https://profiles.viictr.org/profile/265668), Mitsiades N. Inhibition of GATA2 in prostate cancer by a clinically available small molecule. Endocr Relat Cancer. 2021 11 24; 29(1):15-31. PMID: [34636746](//www.ncbi.nlm.nih.gov/pubmed/34636746); PMCID: [PMC8634153](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8634153).

Citations:  Fields:

End EndocrinologyNeo Neoplasms

Translation:HumansCells

  5. Gou X, [Anurag M](https://profiles.viictr.org/profile/15619466), [Lei JT](https://profiles.viictr.org/profile/6998694), Kim BJ, Singh P, Seker S, Fandino D, Han A, Rehman S, Hu J, Korchina V, Doddapaneni H, Dobrolecki LE, Mitsiades N, [Lewis MT](https://profiles.viictr.org/profile/267000), Welm AL, Li S, Lee AV, Robinson DR, [Foulds CE](https://profiles.viictr.org/profile/267919), Ellis MJ. Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer. Cancer Res. 2021 12 15; 81(24):6259-6272. PMID: [34711608](//www.ncbi.nlm.nih.gov/pubmed/34711608); PMCID: [PMC9234971](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9234971).

Citations:  Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  6. Mitsiades N, Kaochar S. Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer. Endocr Relat Cancer. 2021 07 15; 28(8):T19-T38. PMID: [34128827](//www.ncbi.nlm.nih.gov/pubmed/34128827).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34128827/citedby/) Fields:

End EndocrinologyNeo Neoplasms

Translation:Humans

  7. Kaochar S, Mitsiades N. Re: Umang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al. Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. Eur Urol 2020;78:652-6: Can Mutant SPOP Become an Actionable Biomarker for Precision Oncology Management of Prostate Cancer? Eur Urol. 2021 03; 79(3):e91-e93. PMID: [33358624](//www.ncbi.nlm.nih.gov/pubmed/33358624).

Citations:  Fields:

Uro Urology

Translation:Humans

  8. Dhimolea E, de Matos Simoes R, Kansara D, Weng X, Sharma S, Awate P, Liu Z, Gao D, Mitsiades N, Schwab JH, Chen Y, Jeselsohn R, Brown M, Georgakoudi I, Mitsiades CS, Culhane AC. Pleiotropic Mechanisms Drive Endocrine Resistance in the Three-Dimensional Bone Microenvironment. Cancer Res. 2021 01 15; 81(2):371-383. PMID: [32859606](//www.ncbi.nlm.nih.gov/pubmed/32859606); PMCID: [PMC8445072](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8445072).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32859606/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  9. Wu F, Hua Y, Kaochar S, Nie S, Lin YL, Yao Y, Wu J, Wu X, Fu X, [Schiff R](https://profiles.viictr.org/profile/269128), Davis CM, Robertson M, Ehli EA, [Coarfa C](https://profiles.viictr.org/profile/265668), Mitsiades N, Song Y. Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP. J Med Chem. 2020 05 14; 63(9):4716-4731. PMID: [32314924](//www.ncbi.nlm.nih.gov/pubmed/32314924); PMCID: [PMC7340344](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7340344).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32314924/citedby/) Fields:

Che Chemistry

Translation:HumansCells

  10. Geng C, Rajapakshe K, Shah SS, Shou J, Eedunuri VK, Foley C, [Fiskus W](https://profiles.viictr.org/profile/17440164), Rajendran M, Chew SA, Zimmermann M, [Bond R](https://profiles.viictr.org/profile/267583), He B, [Coarfa C](https://profiles.viictr.org/profile/265668), Mitsiades N. Correction: Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer. Cancer Res. 2019 Sep 01; 79(17):4552. PMID: [31481421](//www.ncbi.nlm.nih.gov/pubmed/31481421).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31481421/citedby/) Fields:

Neo Neoplasms

  11. Kaochar S, Mitsiades N. Multimodal action of ONECUT2 in driving neuroendocrine prostate cancer. Transl Cancer Res. 2019 Mar; 8(Suppl 2):S198-S203. PMID: [31360645](//www.ncbi.nlm.nih.gov/pubmed/31360645); PMCID: [PMC6662936](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6662936).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31360645/citedby/)

  12. Bader DA, [Hartig SM](https://profiles.viictr.org/profile/268501), Putluri V, Foley C, Hamilton MP, Smith EA, [Saha PK](https://profiles.viictr.org/profile/265977), Panigrahi A, Walker C, Zong L, Martini-Stoica H, Chen R, Rajapakshe K, [Coarfa C](https://profiles.viictr.org/profile/265668), [Sreekumar A](https://profiles.viictr.org/profile/266636), Mitsiades N, [Bankson JA](https://profiles.viictr.org/profile/12583373), [Ittmann MM](https://profiles.viictr.org/profile/269566), [O'Malley BW](https://profiles.viictr.org/profile/269511), [Putluri N](https://profiles.viictr.org/profile/269361), [McGuire SE](https://profiles.viictr.org/profile/12583840). Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer. Nat Metab. 2019 01; 1(1):70-85. PMID: [31198906](//www.ncbi.nlm.nih.gov/pubmed/31198906); PMCID: [PMC6563330](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6563330).

Citations:
[43](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31198906/citedby/) Fields:

Met Metabolism

Translation:HumansAnimalsCells

  13. Thorek DLJ, Ku AT, Mitsiades N, Veach D, Watson PA, Metha D, Sharma SK, Lewis JS, Abou DS, Lilja HG, Larson SM, McDevitt MR, Strand SE, Ulmert D. Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer. Clin Cancer Res. 2019 01 15; 25(2):881-891. PMID: [30254080](//www.ncbi.nlm.nih.gov/pubmed/30254080); PMCID: [PMC6524527](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6524527).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30254080/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  14. Kaochar S, Mitsiades N. A Novel Mechanism to Drive Castration-Resistant Prostate Cancer. Trends Endocrinol Metab. 2018 06; 29(6):366-368. PMID: [29605661](//www.ncbi.nlm.nih.gov/pubmed/29605661); PMCID: [PMC5960430](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5960430).

Citations:  Fields:

End EndocrinologyMet Metabolism

Translation:HumansCells

  15. Kaochar S, Dong J, Torres M, Rajapakshe K, Nikolos F, Davis CM, Ehli EA, [Coarfa C](https://profiles.viictr.org/profile/265668), Mitsiades N, Poulaki V. ICG-001 Exerts Potent Anticancer Activity Against Uveal Melanoma Cells. Invest Ophthalmol Vis Sci. 2018 01 01; 59(1):132-143. PMID: [29332125](//www.ncbi.nlm.nih.gov/pubmed/29332125); PMCID: [PMC5769500](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5769500).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29332125/citedby/) Fields:

Oph Ophthalmology

Translation:AnimalsCells

  16. Flaig TW, Plets M, Hussain MHA, Agarwal N, Mitsiades N, Deshpande HA, Vaishampayan UN, Thompson IM. Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction. JAMA Oncol. 2017 Nov 09; 3(11):e170231. PMID: [28358937](//www.ncbi.nlm.nih.gov/pubmed/28358937); PMCID: [PMC5824213](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5824213).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28358937/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  17. Wu F, Dai X, Gan W, Wan L, Li M, Mitsiades N, Wei W, Ding Q, Zhang J. Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation. Cancer Lett. 2017 01 28; 385:207-214. PMID: [27780719](//www.ncbi.nlm.nih.gov/pubmed/27780719); PMCID: [PMC5148662](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5148662).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27780719/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  18. Xiao L, [Feng Q](https://profiles.viictr.org/profile/267850), Zhang Z, Wang F, [Lydon JP](https://profiles.viictr.org/profile/269737), [Ittmann MM](https://profiles.viictr.org/profile/269566), [Xin L](https://profiles.viictr.org/profile/265825), Mitsiades N, He B. The essential role of GATA transcription factors in adult murine prostate. Oncotarget. 2016 Jul 26; 7(30):47891-47903. PMID: [27374105](//www.ncbi.nlm.nih.gov/pubmed/27374105); PMCID: [PMC5216986](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5216986).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27374105/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimals

  19. Kaushik AK, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, Zaslavsky A, Putluri V, Vasu VT, Zhang Y, Khan AS, Lloyd S, Szafran AT, [Dasgupta S](https://profiles.viictr.org/profile/3010259), Bader DA, Stossi F, Li H, Samanta S, Cao X, Tsouko E, [Huang S](https://profiles.viictr.org/profile/267743), Frigo DE, [Chan L](https://profiles.viictr.org/profile/269461), Edwards DP, [Kaipparettu BA](https://profiles.viictr.org/profile/269257), Mitsiades N, [Weigel NL](https://profiles.viictr.org/profile/266556), [Mancini M](https://profiles.viictr.org/profile/268178), [McGuire SE](https://profiles.viictr.org/profile/12583840), Mehra R, [Ittmann MM](https://profiles.viictr.org/profile/269566), Chinnaiyan AM, [Putluri N](https://profiles.viictr.org/profile/269361), Palapattu GS, Michailidis G, [Sreekumar A](https://profiles.viictr.org/profile/266636). Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nat Commun. 2016 05 19; 7:11612. PMID: [27194471](//www.ncbi.nlm.nih.gov/pubmed/27194471); PMCID: [PMC4874037](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4874037).

Citations:
[31](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27194471/citedby/) Fields:

Bio BiologySci Science

Translation:HumansAnimalsCells

  20. [Nikolai BC](https://profiles.viictr.org/profile/1826673), [Lanz RB](https://profiles.viictr.org/profile/267684), York B, [Dasgupta S](https://profiles.viictr.org/profile/3010259), Mitsiades N, [Creighton CJ](https://profiles.viictr.org/profile/265729), Tsimelzon A, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), [Lonard DM](https://profiles.viictr.org/profile/269800), Smith CL, [O'Malley BW](https://profiles.viictr.org/profile/269511). HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes. Cancer Res. 2016 Mar 15; 76(6):1463-75. PMID: [26833126](//www.ncbi.nlm.nih.gov/pubmed/26833126); PMCID: [PMC4794399](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4794399).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26833126/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  21. Foley C, Mitsiades N. Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer. Horm Cancer. 2016 Apr; 7(2):84-103. PMID: [26728473](//www.ncbi.nlm.nih.gov/pubmed/26728473); PMCID: [PMC5380740](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5380740).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26728473/citedby/) Fields:

End EndocrinologyNeo Neoplasms

Translation:HumansAnimalsCells

  22. [Fiskus W](https://profiles.viictr.org/profile/17440164), Mitsiades N. B-Raf Inhibition in the Clinic: Present and Future. Annu Rev Med. 2016; 67:29-43. PMID: [26768236](//www.ncbi.nlm.nih.gov/pubmed/26768236).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26768236/citedby/) Fields:

Med Medicine (General)

Translation:HumansCells

  23. Eedunuri VK, Rajapakshe K, [Fiskus W](https://profiles.viictr.org/profile/17440164), Geng C, Chew SA, Foley C, Shah SS, Shou J, Mohamed JS, [Coarfa C](https://profiles.viictr.org/profile/265668), [O'Malley BW](https://profiles.viictr.org/profile/269511), Mitsiades N. miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation. Mol Endocrinol. 2015 Aug; 29(8):1170-83. PMID: [26066330](//www.ncbi.nlm.nih.gov/pubmed/26066330); PMCID: [PMC4518002](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4518002).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26066330/citedby/) Fields:

End EndocrinologyMol Molecular Biology

Translation:HumansCells

  24. [Dasgupta S](https://profiles.viictr.org/profile/3010259), [Putluri N](https://profiles.viictr.org/profile/269361), Long W, Zhang B, Wang J, Kaushik AK, Arnold JM, Bhowmik SK, Stashi E, Brennan CA, Rajapakshe K, [Coarfa C](https://profiles.viictr.org/profile/265668), Mitsiades N, [Ittmann MM](https://profiles.viictr.org/profile/269566), Chinnaiyan AM, [Sreekumar A](https://profiles.viictr.org/profile/266636), [O'Malley BW](https://profiles.viictr.org/profile/269511). Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis. J Clin Invest. 2015 Mar 02; 125(3):1174-88. PMID: [25664849](//www.ncbi.nlm.nih.gov/pubmed/25664849); PMCID: [PMC4362260](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4362260).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25664849/citedby/) Fields:

Med Medicine (General)

Translation:HumansAnimalsCells

  25. He B, [Lanz RB](https://profiles.viictr.org/profile/267684), [Fiskus W](https://profiles.viictr.org/profile/17440164), Geng C, Yi P, [Hartig SM](https://profiles.viictr.org/profile/268501), Rajapakshe K, Shou J, Wei L, Shah SS, Foley C, Chew SA, Eedunuri VK, Bedoya DJ, [Feng Q](https://profiles.viictr.org/profile/267850), Minami T, Mitsiades CS, Frolov A, [Weigel NL](https://profiles.viictr.org/profile/266556), [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), Rosen DG, [Palzkill T](https://profiles.viictr.org/profile/269759), [Ittmann MM](https://profiles.viictr.org/profile/269566), Song Y, [Coarfa C](https://profiles.viictr.org/profile/265668), [O'Malley BW](https://profiles.viictr.org/profile/269511), Mitsiades N. GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex. Proc Natl Acad Sci U S A. 2014 Dec 23; 111(51):18261-6. PMID: [25489091](//www.ncbi.nlm.nih.gov/pubmed/25489091); PMCID: [PMC4280633](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4280633).

Citations:
[55](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25489091/citedby/) Fields:

Sci Science

Translation:HumansCells

  26. Geng C, Rajapakshe K, Shah SS, Shou J, Eedunuri VK, Foley C, [Fiskus W](https://profiles.viictr.org/profile/17440164), Rajendran M, Chew SA, Zimmermann M, [Bond R](https://profiles.viictr.org/profile/267583), He B, [Coarfa C](https://profiles.viictr.org/profile/265668), Mitsiades N. Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer. Cancer Res. 2014 Oct 01; 74(19):5631-43. PMID: [25274033](//www.ncbi.nlm.nih.gov/pubmed/25274033); PMCID: [PMC4209379](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4209379).

Citations:
[80](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25274033/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  27. [Feng Q](https://profiles.viictr.org/profile/267850), Zhang Z, Shea MJ, [Creighton CJ](https://profiles.viictr.org/profile/265729), [Coarfa C](https://profiles.viictr.org/profile/265668), [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), [Lanz R](https://profiles.viictr.org/profile/267684), He B, Wang L, Fu X, Nardone A, [Song Y](https://profiles.viictr.org/profile/266042), Bradner J, Mitsiades N, Mitsiades CS, Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128), [O'Malley BW](https://profiles.viictr.org/profile/269511). An epigenomic approach to therapy for tamoxifen-resistant breast cancer. Cell Res. 2014 Jul; 24(7):809-19. PMID: [24874954](//www.ncbi.nlm.nih.gov/pubmed/24874954); PMCID: [PMC4085766](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4085766).

Citations:
[96](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24874954/citedby/) Fields:

Cel Cell Biology

Translation:HumansAnimalsCells

  28. Cerne JZ, [Hartig SM](https://profiles.viictr.org/profile/268501), Hamilton MP, Chew SA, Mitsiades N, Poulaki V, [McGuire SE](https://profiles.viictr.org/profile/12583840). Protein kinase C inhibitors sensitize GNAQ mutant uveal melanoma cells to ionizing radiation. Invest Ophthalmol Vis Sci. 2014 Apr 07; 55(4):2130-9. PMID: [24595385](//www.ncbi.nlm.nih.gov/pubmed/24595385); PMCID: [PMC3979518](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3979518).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24595385/citedby/) Fields:

Oph Ophthalmology

Translation:HumansCells

  29. Vareed SK, Basu S, Putluri V, [Putluri N](https://profiles.viictr.org/profile/269361), Panzitt K, Brennan CA, Chinnaiyan AM, Vergara IA, Erho N, [Weigel NL](https://profiles.viictr.org/profile/266556), Mitsiades N, Shojaie A, Palapattu G, Michailidis G, [Sreekumar A](https://profiles.viictr.org/profile/266636), Kaushik AK. Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer. J Proteome Res. 2014 Feb 07; 13(2):1088-100. PMID: [24359151](//www.ncbi.nlm.nih.gov/pubmed/24359151); PMCID: [PMC3975657](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3975657).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24359151/citedby/) Fields:

Bio Biochemistry

Translation:HumansCells

  30. Mitsiades N. A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer. Cancer Res. 2013 Aug 01; 73(15):4599-605. PMID: [23887973](//www.ncbi.nlm.nih.gov/pubmed/23887973).

Citations:
[53](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23887973/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  31. Geng C, He B, Xu L, Barbieri CE, Eedunuri VK, Chew SA, Zimmermann M, [Bond R](https://profiles.viictr.org/profile/267583), Shou J, Li C, Blattner M, [Lonard DM](https://profiles.viictr.org/profile/269800), Demichelis F, [Coarfa C](https://profiles.viictr.org/profile/265668), Rubin MA, Zhou P, [O'Malley BW](https://profiles.viictr.org/profile/269511), Mitsiades N. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. Proc Natl Acad Sci U S A. 2013 Apr 23; 110(17):6997-7002. PMID: [23559371](//www.ncbi.nlm.nih.gov/pubmed/23559371); PMCID: [PMC3637757](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3637757).

Citations:
[124](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23559371/citedby/)
Fields:

Sci Science

Translation:HumansCells

  32. Bedoya DJ, Mitsiades N. Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: patient considerations, novel opportunities, and future directions. Onco Targets Ther. 2013; 6:9-18. PMID: [23319868](//www.ncbi.nlm.nih.gov/pubmed/23319868); PMCID: [PMC3540953](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3540953).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23319868/citedby/)

  33. Mitsiades N, Sung CC, Schultz N, Danila DC, He B, Eedunuri VK, Fleisher M, Sander C, Sawyers CL, Scher HI. Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors. Cancer Res. 2012 Dec 01; 72(23):6142-52. PMID: [22971343](//www.ncbi.nlm.nih.gov/pubmed/22971343); PMCID: [PMC3685485](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3685485).

Citations:
[102](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22971343/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCells

  34. Bedoya DJ, Mitsiades N. Abiraterone acetate, a first-in-class CYP17 inhibitor, establishes a new treatment paradigm in castration-resistant prostate cancer. Expert Rev Anticancer Ther. 2012 Jan; 12(1):1-3. PMID: [22149426](//www.ncbi.nlm.nih.gov/pubmed/22149426).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22149426/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:Humans

  35. Mitsiades N, Pazaitou-Panayiotou K, Aronis KN, Moon HS, Chamberland JP, Liu X, Diakopoulos KN, Kyttaris V, Panagiotou V, Mylvaganam G, Tseleni-Balafouta S, Mantzoros CS. Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies. J Clin Endocrinol Metab. 2011 Dec; 96(12):E2023-8. PMID: [21937620](//www.ncbi.nlm.nih.gov/pubmed/21937620); PMCID: [PMC3232611](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3232611).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21937620/citedby/) Fields:

End EndocrinologyMet Metabolism

Translation:Humans

  36. Mitsiades N, Chew SA, He B, Riechardt AI, Karadedou T, Kotoula V, Poulaki V. Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy. Invest Ophthalmol Vis Sci. 2011 Sep 14; 52(10):7248-55. PMID: [21828154](//www.ncbi.nlm.nih.gov/pubmed/21828154); PMCID: [PMC3207725](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3207725).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21828154/citedby/) Fields:

Oph Ophthalmology

Translation:HumansCells

  37. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, Landers T, Dolgalev I, Major JE, Wilson M, Socci ND, Lash AE, Heguy A, Eastham JA, Scher HI, Reuter VE, Scardino PT, Sander C, Sawyers CL, Gerald WL. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010 Jul 13; 18(1):11-22. PMID: [20579941](//www.ncbi.nlm.nih.gov/pubmed/20579941); PMCID: [PMC3198787](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3198787).

Citations:
[1877](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20579941/citedby/)
Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  38. McMillin DW, Delmore J, Weisberg E, Negri JM, Geer DC, Klippel S, Mitsiades N, Schlossman RL, Munshi NC, Kung AL, Griffin JD, Richardson PG, Anderson KC, Mitsiades CS. Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nat Med. 2010 Apr; 16(4):483-9. PMID: [20228816](//www.ncbi.nlm.nih.gov/pubmed/20228816); PMCID: [PMC3786785](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3786785).

Citations:
[165](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20228816/citedby/)
Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansCells

  39. Takada Y, Ono Y, Saegusa J, Sagusa J, Mitsiades C, Mitsiades N, Tsai J, He Y, Maningding E, Coleman A, Ramirez-Maverakis D, Rodrigues R, Rodriquez R, Takada Y, Maverakis E. A T cell-binding fragment of fibrinogen can prevent autoimmunity. J Autoimmun. 2010 Jun; 34(4):453-9. PMID: [20036106](//www.ncbi.nlm.nih.gov/pubmed/20036106); PMCID: [PMC2860040](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2860040).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20036106/citedby/) Fields:

All Allergy and Immunology

Translation:AnimalsCells

  40. Ooi MG, Hayden PJ, Kotoula V, McMillin DW, Charalambous E, Daskalaki E, Raje NS, Munshi NC, Chauhan D, Hideshima T, Buon L, Clynes M, O'Gorman P, Richardson PG, Mitsiades CS, Anderson KC, Mitsiades N. Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib. Clin Cancer Res. 2009 Dec 01; 15(23):7153-60. PMID: [19934289](//www.ncbi.nlm.nih.gov/pubmed/19934289); PMCID: [PMC3672410](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3672410).

Citations:
[31](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19934289/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  41. Negri JM, McMillin DW, Delmore J, Mitsiades N, Hayden P, Klippel S, Hideshima T, Chauhan D, Munshi NC, Buser CA, Pollard J, Richardson PG, Anderson KC, Mitsiades CS. In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465. Br J Haematol. 2009 Dec; 147(5):672-6. PMID: [19751238](//www.ncbi.nlm.nih.gov/pubmed/19751238); PMCID: [PMC3672411](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3672411).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19751238/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  42. Iliaki E, Poulaki V, Mitsiades N, Mitsiades CS, Miller JW, Gragoudas ES. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009 Oct; 50(10):4898-904. PMID: [19553613](//www.ncbi.nlm.nih.gov/pubmed/19553613).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19553613/citedby/) Fields:

Oph Ophthalmology

Translation:AnimalsCells

  43. Poulaki V, Mitsiades CS, Kotoula V, Negri J, McMullan C, Miller JW, Marks PA, Mitsiades N. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications. Invest Ophthalmol Vis Sci. 2009 Sep; 50(9):4072-9. PMID: [19387079](//www.ncbi.nlm.nih.gov/pubmed/19387079).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19387079/citedby/) Fields:

Oph Ophthalmology

Translation:HumansCells

  44. Kotoula V, Sozopoulos E, Litsiou H, Fanourakis G, Koletsa T, Voutsinas G, Tseleni-Balafouta S, Mitsiades CS, Wellmann A, Mitsiades N. Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas. Endocr Relat Cancer. 2009 Jun; 16(2):565-72. PMID: [19190079](//www.ncbi.nlm.nih.gov/pubmed/19190079).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19190079/citedby/) Fields:

End EndocrinologyNeo Neoplasms

Translation:HumansCells

  45. Dalamaga M, Migdalis I, Fargnoli JL, Papadavid E, Bloom E, Mitsiades N, Karmaniolas K, Pelecanos N, Tseleni-Balafouta S, Dionyssiou-Asteriou A, Mantzoros CS. Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control. 2009 Jul; 20(5):625-33. PMID: [19051043](//www.ncbi.nlm.nih.gov/pubmed/19051043); PMCID: [PMC2720089](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2720089).

Citations:
[54](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19051043/citedby/) Fields:

Epi EpidemiologyNeo Neoplasms

Translation:Humans

  46. Mitsiades N, Correa D, Gross CP, Hurria A, Slovin SF. Cognitive effects of hormonal therapy in older adults. Semin Oncol. 2008 Dec; 35(6):569-81. PMID: [19027461](//www.ncbi.nlm.nih.gov/pubmed/19027461).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19027461/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  47. Fagin JA, Mitsiades N. Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract Res Clin Endocrinol Metab. 2008 Dec; 22(6):955-69. PMID: [19041825](//www.ncbi.nlm.nih.gov/pubmed/19041825); PMCID: [PMC2615540](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2615540).

Citations:
[49](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19041825/citedby/) Fields:

End EndocrinologyMet Metabolism

Translation:Humans

  48. Mitsiades CS, Ocio EM, Pandiella A, Maiso P, Gajate C, Garayoa M, Vilanova D, Montero JC, Mitsiades N, McMullan CJ, Munshi NC, Hideshima T, Chauhan D, Aviles P, Otero G, Faircloth G, Mateos MV, Richardson PG, Mollinedo F, San-Miguel JF, Anderson KC. Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo. Cancer Res. 2008 Jul 01; 68(13):5216-25. PMID: [18593922](//www.ncbi.nlm.nih.gov/pubmed/18593922).

Citations:
[45](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18593922/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  49. Petridou ET, Mitsiades N, Gialamas S, Angelopoulos M, Skalkidou A, Dessypris N, Hsi A, Lazaris N, Polyzos A, Syrigos C, Brennan AM, Tseleni-Balafouta S, Mantzoros CS. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies. Oncology. 2007; 73(3-4):261-9. PMID: [18424891](//www.ncbi.nlm.nih.gov/pubmed/18424891).

Citations:
[34](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18424891/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  50. Williams CJ, Mitsiades N, Sozopoulos E, Hsi A, Wolk A, Nifli AP, Tseleni-Balafouta S, Mantzoros CS. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer. 2008 Mar; 15(1):289-99. PMID: [18310295](//www.ncbi.nlm.nih.gov/pubmed/18310295).

Citations:
[38](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18310295/citedby/) Fields:

End EndocrinologyNeo Neoplasms

Translation:Humans

  51. Poulaki V, Mitsiades CS, Kotoula V, Negri J, McMillin D, Miller JW, Mitsiades N. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro. Invest Ophthalmol Vis Sci. 2007 Oct; 48(10):4706-19. PMID: [17898295](//www.ncbi.nlm.nih.gov/pubmed/17898295).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17898295/citedby/) Fields:

Oph Ophthalmology

Translation:HumansCells

  52. Mitsiades CS, Hayden P, Kotoula V, McMillin DW, McMullan C, Negri J, Delmore JE, Poulaki V, Mitsiades N. Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition. J Clin Endocrinol Metab. 2007 Dec; 92(12):4845-52. PMID: [17848408](//www.ncbi.nlm.nih.gov/pubmed/17848408).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17848408/citedby/) Fields:

End EndocrinologyMet Metabolism

Translation:HumansCells

  53. Mitsiades CS, Mitsiades NS, Richardson PG, Munshi NC, Anderson KC. Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment. J Cell Biochem. 2007 Jul 01; 101(4):950-68. PMID: [17546631](//www.ncbi.nlm.nih.gov/pubmed/17546631).

Citations:
[41](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17546631/citedby/) Fields:

Bio BiochemistryCel Cell Biology

Translation:HumansAnimalsCells

  54. Wadhera A, Maverakis E, Mitsiades N, Lara PN, Fung MA, Lynch PJ. Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease. J Am Acad Dermatol. 2007 Oct; 57(4):683-9. PMID: [17433850](//www.ncbi.nlm.nih.gov/pubmed/17433850).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17433850/citedby/) Fields:

Der Dermatology

Translation:Humans

  55. Poulaki V, Iliaki E, Mitsiades N, Mitsiades CS, Paulus YN, Bula DV, Gragoudas ES, Miller JW. Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis. FASEB J. 2007 Jul; 21(9):2113-23. PMID: [17400913](//www.ncbi.nlm.nih.gov/pubmed/17400913).

Citations:
[36](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17400913/citedby/) Fields:

Bio BiologyPhy Physiology

Translation:AnimalsCells

  56. Mitsiades CS, Negri J, McMullan C, McMillin DW, Sozopoulos E, Fanourakis G, Voutsinas G, Tseleni-Balafouta S, Poulaki V, Batt D, Mitsiades N. Targeting BRAFV600E in thyroid carcinoma: therapeutic implications. Mol Cancer Ther. 2007 Mar; 6(3):1070-8. PMID: [17363500](//www.ncbi.nlm.nih.gov/pubmed/17363500).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17363500/citedby/) Fields:

Ant Antineoplastic Agents

Translation:HumansCells

  57. Michalakis K, Williams CJ, Mitsiades N, Blakeman J, Balafouta-Tselenis S, Giannopoulos A, Mantzoros CS. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev. 2007 Feb; 16(2):308-13. PMID: [17301264](//www.ncbi.nlm.nih.gov/pubmed/17301264).

Citations:
[60](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17301264/citedby/) Fields:

Bio BiochemistryEpi EpidemiologyNeo Neoplasms

Translation:Humans

  58. Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S, Mitsiades N, Kiess W, Mantzoros CS, K?rner A. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab. 2007 Mar; 92(3):1041-8. PMID: [17192291](//www.ncbi.nlm.nih.gov/pubmed/17192291).

Citations:
[89](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17192291/citedby/) Fields:

End EndocrinologyMet Metabolism

Translation:HumansCells

  59. Chauhan D, Neri P, Velankar M, Podar K, Hideshima T, Fulciniti M, Tassone P, Raje N, Mitsiades C, Mitsiades N, Richardson P, Zawel L, Tran M, Munshi N, Anderson KC. Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM). Blood. 2007 Feb 01; 109(3):1220-7. PMID: [17032924](//www.ncbi.nlm.nih.gov/pubmed/17032924); PMCID: [PMC1785138](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1785138).

Citations:
[51](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17032924/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCells

  60. Mitsiades CS, Mitsiades N, Hideshima T, Richardson PG, Anderson KC. Proteasome inhibition as a new therapeutic principle in hematological malignancies. Curr Drug Targets. 2006 Oct; 7(10):1341-7. PMID: [17073596](//www.ncbi.nlm.nih.gov/pubmed/17073596).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17073596/citedby/) Fields:

Dru Drug Therapy

Translation:HumansAnimals

  61. Mitsiades CS, McMillin D, Kotoula V, Poulaki V, McMullan C, Negri J, Fanourakis G, Tseleni-Balafouta S, Ain KB, Mitsiades N. Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro. J Clin Endocrinol Metab. 2006 Oct; 91(10):4013-21. PMID: [16849420](//www.ncbi.nlm.nih.gov/pubmed/16849420).

Citations:
[48](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16849420/citedby/) Fields:

End EndocrinologyMet Metabolism

Translation:HumansCells

  62. Mitsiades CS, Kotoula V, Poulaki V, Sozopoulos E, Negri J, Charalambous E, Fanourakis G, Voutsinas G, Tseleni-Balafouta S, Mitsiades N. Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis. J Clin Endocrinol Metab. 2006 Sep; 91(9):3662-6. PMID: [16822827](//www.ncbi.nlm.nih.gov/pubmed/16822827).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16822827/citedby/) Fields:

End EndocrinologyMet Metabolism

Translation:HumansCells

  63. Mitsiades CS, Poulaki V, Fanourakis G, Sozopoulos E, McMillin D, Wen Z, Voutsinas G, Tseleni-Balafouta S, Mitsiades N. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. Clin Cancer Res. 2006 Jun 15; 12(12):3705-12. PMID: [16778096](//www.ncbi.nlm.nih.gov/pubmed/16778096).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16778096/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  64. Mitsiades CS, Mitsiades NS, Munshi NC, Richardson PG, Anderson KC. The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions. Eur J Cancer. 2006 Jul; 42(11):1564-73. PMID: [16765041](//www.ncbi.nlm.nih.gov/pubmed/16765041).

Citations:
[87](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16765041/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  65. Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Kung AL, Davies FE, Morgan G, Akiyama M, Shringarpure R, Munshi NC, Richardson PG, Hideshima T, Chauhan D, Gu X, Bailey C, Joseph M, Libermann TA, Rosen NS, Anderson KC. Antimyeloma activity of heat shock protein-90 inhibition. Blood. 2006 Feb 01; 107(3):1092-100. PMID: [16234364](//www.ncbi.nlm.nih.gov/pubmed/16234364); PMCID: [PMC1895907](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895907).

Citations:
[100](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16234364/citedby/)
Fields:

Hem Hematology

Translation:HumansCells

  66. Chauhan D, Li G, Podar K, Hideshima T, Neri P, He D, Mitsiades N, Richardson P, Chang Y, Schindler J, Carver B, Anderson KC. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells. Cancer Res. 2005 Sep 15; 65(18):8350-8. PMID: [16166312](//www.ncbi.nlm.nih.gov/pubmed/16166312).

Citations:
[46](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16166312/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  67. Mitsiades CS, Mitsiades N, Hideshima T, Richardson PG, Anderson KC. Proteasome inhibition as a therapeutic strategy for hematologic malignancies. Expert Rev Anticancer Ther. 2005 Jun; 5(3):465-76. PMID: [16001954](//www.ncbi.nlm.nih.gov/pubmed/16001954).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16001954/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:Humans

  68. Mitsiades CS, Mitsiades N. Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling. Expert Rev Anticancer Ther. 2005 Jun; 5(3):487-99. PMID: [16001956](//www.ncbi.nlm.nih.gov/pubmed/16001956).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16001956/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansCells

  69. Mitsiades CS, Poulaki V, McMullan C, Negri J, Fanourakis G, Goudopoulou A, Richon VM, Marks PA, Mitsiades N. Novel histone deacetylase inhibitors in the treatment of thyroid cancer. Clin Cancer Res. 2005 May 15; 11(10):3958-65. PMID: [15897598](//www.ncbi.nlm.nih.gov/pubmed/15897598).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15897598/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  70. Mitsiades CS, Mitsiades N. Thyroid carcinoma cells and Fas-mediated apoptosis. Thyroid. 2005 Feb; 15(2):178-9. PMID: [15812903](//www.ncbi.nlm.nih.gov/pubmed/15812903).

Citations:  Fields:

End Endocrinology

Translation:Humans

  71. Mitsiades CS, Mitsiades N, Hideshima T, Richardson PG, Anderson KC. Proteasome inhibitors as therapeutics. Essays Biochem. 2005; 41:205-18. PMID: [16250907](//www.ncbi.nlm.nih.gov/pubmed/16250907).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16250907/citedby/) Fields:

Bio Biochemistry

Translation:Humans

  72. Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J, Goudopoulou A, Halikias IX, Voutsinas G, Tseleni-Balafouta S, Miller JW, Mitsiades N. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing. Invest Ophthalmol Vis Sci. 2005 Jan; 46(1):358-66. PMID: [15623796](//www.ncbi.nlm.nih.gov/pubmed/15623796).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15623796/citedby/) Fields:

Oph Ophthalmology

Translation:HumansCells

  73. Mitsiades CS, Mitsiades N, Munshi NC, Anderson KC. Focus on multiple myeloma. Cancer Cell. 2004 Nov; 6(5):439-44. PMID: [15542427](//www.ncbi.nlm.nih.gov/pubmed/15542427).

Citations:
[47](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15542427/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  74. Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP. Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol. 2004 Aug; 165(2):457-69. PMID: [15277220](//www.ncbi.nlm.nih.gov/pubmed/15277220); PMCID: [PMC1618554](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1618554).

Citations:
[57](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15277220/citedby/) Fields:

Pat Pathology

Translation:HumansAnimalsCells

  75. Mitsiades CS, Mitsiades N. CC-5013 (Celgene). Curr Opin Investig Drugs. 2004 Jun; 5(6):635-47. PMID: [15242253](//www.ncbi.nlm.nih.gov/pubmed/15242253).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15242253/citedby/) Fields:

Dru Drug Therapy

Translation:HumansAnimals

  76. Mitsiades CS, Mitsiades N, Koutsilieris M. The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets. 2004 May; 4(3):235-56. PMID: [15134532](//www.ncbi.nlm.nih.gov/pubmed/15134532).

Citations:
[73](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15134532/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:HumansAnimalsCells

  77. Poulaki V, Mitsiades N, Kruse FE, Radetzky S, Iliaki E, Kirchhof B, Joussen AM. Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression. Am J Pathol. 2004 Apr; 164(4):1293-302. PMID: [15039217](//www.ncbi.nlm.nih.gov/pubmed/15039217); PMCID: [PMC1615358](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1615358).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15039217/citedby/) Fields:

Pat Pathology

Translation:HumansAnimalsCells

  78. Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Akiyama M, Hideshima T, Chauhan D, Joseph M, Libermann TA, Pearson MA, Hofmann F, Anderson KC, Kung AL, Garc?a-Echeverr?a C. Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell. 2004 Mar; 5(3):221-30. PMID: [15050914](//www.ncbi.nlm.nih.gov/pubmed/15050914).

Citations:
[171](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15050914/citedby/)
Fields:

Neo Neoplasms

Translation:Humans

  79. Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Hideshima T, Akiyama M, Chauhan D, Munshi N, Gu X, Bailey C, Joseph M, Libermann TA, Richon VM, Marks PA, Anderson KC. Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications. Proc Natl Acad Sci U S A. 2004 Jan 13; 101(2):540-5. PMID: [14695887](//www.ncbi.nlm.nih.gov/pubmed/14695887); PMCID: [PMC327183](//www.ncbi.nlm.nih.gov/pmc/articles/PMC327183).

Citations:
[194](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14695887/citedby/)
Fields:

Sci Science

Translation:HumansCells

  80. Hideshima T, Chauhan D, Hayashi T, Podar K, Akiyama M, Mitsiades C, MItsiades N, Gong B, Bonham L, de Vries P, Munshi N, Richardson PG, Singer JW, Anderson KC. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma. Cancer Res. 2003 Dec 01; 63(23):8428-36. PMID: [14679006](//www.ncbi.nlm.nih.gov/pubmed/14679006).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14679006/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  81. Hideshima T, Chauhan D, Hayashi T, Akiyama M, Mitsiades N, Mitsiades C, Podar K, Munshi NC, Richardson PG, Anderson KC. Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma. Oncogene. 2003 Nov 20; 22(52):8386-93. PMID: [14627979](//www.ncbi.nlm.nih.gov/pubmed/14627979).

Citations:
[48](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14627979/citedby/) Fields:

Mol Molecular BiologyNeo Neoplasms

Translation:HumansCells

  82. Poulaki V, Mitsiades CS, McMullan C, Sykoutri D, Fanourakis G, Kotoula V, Tseleni-Balafouta S, Koutras DA, Mitsiades N. Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas. J Clin Endocrinol Metab. 2003 Nov; 88(11):5392-8. PMID: [14602779](//www.ncbi.nlm.nih.gov/pubmed/14602779).

Citations:
[31](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14602779/citedby/) Fields:

End EndocrinologyMet Metabolism

Translation:HumansCells

  83. Mitsiades CS, Mitsiades NS, Bronson RT, Chauhan D, Munshi N, Treon SP, Maxwell CA, Pilarski L, Hideshima T, Hoffman RM, Anderson KC. Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications. Cancer Res. 2003 Oct 15; 63(20):6689-96. PMID: [14583463](//www.ncbi.nlm.nih.gov/pubmed/14583463).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14583463/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimals

  84. Mitsiades CS, Sykoutri D, McMullan C, Poulaki V, Mitsiades N. Effect of imatinib mesylate (Gleevec) on anaplastic thyroid carcinoma cell lines. J Clin Endocrinol Metab. 2003 Oct; 88(10):5043-4; author reply 5044. PMID: [14557495](//www.ncbi.nlm.nih.gov/pubmed/14557495).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14557495/citedby/) Fields:

End EndocrinologyMet Metabolism

Translation:HumansCells

  85. LeBlanc R, Hideshima T, Catley LP, Shringarpure R, Burger R, Mitsiades N, Mitsiades C, Cheema P, Chauhan D, Richardson PG, Anderson KC, Munshi NC. Immunomodulatory drug costimulates T cells via the B7-CD28 pathway. Blood. 2004 Mar 01; 103(5):1787-90. PMID: [14512311](//www.ncbi.nlm.nih.gov/pubmed/14512311).

Citations:
[113](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14512311/citedby/)
Fields:

Hem Hematology

Translation:HumansCells

  86. Chauhan D, Li G, Sattler M, Podar K, Mitsiades C, Mitsiades N, Munshi N, Hideshima T, Anderson KC. Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cells. Oncogene. 2003 Sep 18; 22(40):6296-300. PMID: [13679868](//www.ncbi.nlm.nih.gov/pubmed/13679868).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/13679868/citedby/) Fields:

Mol Molecular BiologyNeo Neoplasms

Translation:HumansCells

  87. Tai YT, Podar K, Catley L, Tseng YH, Akiyama M, Shringarpure R, Burger R, Hideshima T, Chauhan D, Mitsiades N, Richardson P, Munshi NC, Kahn CR, Mitsiades C, Anderson KC. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signaling. Cancer Res. 2003 09 15; 63(18):5850-8. PMID: [14522909](//www.ncbi.nlm.nih.gov/pubmed/14522909).

Citations:
[67](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14522909/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  88. Munshi NC, Hideshima T, Carrasco D, Shammas M, Auclair D, Davies F, Mitsiades N, Mitsiades C, Kim RS, Li C, Rajkumar SV, Fonseca R, Bergsagel L, Chauhan D, Anderson KC. Identification of genes modulated in multiple myeloma using genetically identical twin samples. Blood. 2004 Mar 01; 103(5):1799-806. PMID: [12969976](//www.ncbi.nlm.nih.gov/pubmed/12969976).

Citations:
[57](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12969976/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  89. Davies FE, Dring AM, Li C, Rawstron AC, Shammas MA, O'Connor SM, Fenton JA, Hideshima T, Chauhan D, Tai IT, Robinson E, Auclair D, Rees K, Gonzalez D, Ashcroft AJ, Dasgupta R, Mitsiades C, Mitsiades N, Chen LB, Wong WH, Munshi NC, Morgan GJ, Anderson KC. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. Blood. 2003 Dec 15; 102(13):4504-11. PMID: [12947006](//www.ncbi.nlm.nih.gov/pubmed/12947006).

Citations:
[82](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12947006/citedby/) Fields:

Hem Hematology

Translation:Humans

  90. Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N, Catley L, Tai YT, Hayashi T, Shringarpure R, Burger R, Munshi N, Ohtake Y, Saxena S, Anderson KC. Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance. Blood. 2003 Nov 01; 102(9):3379-86. PMID: [12855565](//www.ncbi.nlm.nih.gov/pubmed/12855565).

Citations:
[45](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12855565/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  91. Catley L, Weisberg E, Tai YT, Atadja P, Remiszewski S, Hideshima T, Mitsiades N, Shringarpure R, LeBlanc R, Chauhan D, Munshi NC, Schlossman R, Richardson P, Griffin J, Anderson KC. NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma. Blood. 2003 Oct 01; 102(7):2615-22. PMID: [12816865](//www.ncbi.nlm.nih.gov/pubmed/12816865).

Citations:
[67](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12816865/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCells

  92. Mitsiades CS, Mitsiades N. P2X7 polymorphism and chronic lymphocytic leukaemia. Lancet. 2003 Apr 26; 361(9367):1478; author reply 1478-9. PMID: [12727428](//www.ncbi.nlm.nih.gov/pubmed/12727428).

Citations:  Fields:

Med Medicine (General)

Translation:Humans

  93. Mitsiades CS, Mitsiades N, Treon SP, Anderson KC. Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasias. Semin Oncol. 2003 Apr; 30(2):156-60. PMID: [12720127](//www.ncbi.nlm.nih.gov/pubmed/12720127).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12720127/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  94. Treon SP, Kelliher A, Keele B, Frankel S, Emmanouilides C, Kimby E, Schlossman R, Mitsiades N, Mitsiades C, Preffer F, Anderson KC. Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations. Semin Oncol. 2003 Apr; 30(2):248-52. PMID: [12720146](//www.ncbi.nlm.nih.gov/pubmed/12720146).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12720146/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  95. Mitsiades CS, Mitsiades N, Richardson PG, Treon SP, Anderson KC. Novel biologically based therapies for Waldenstrom's macroglobulinemia. Semin Oncol. 2003 Apr; 30(2):309-12. PMID: [12720159](//www.ncbi.nlm.nih.gov/pubmed/12720159).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12720159/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  96. Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N, Munshi N, Kharbanda S, Anderson KC. JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells. J Biol Chem. 2003 May 16; 278(20):17593-6. PMID: [12665525](//www.ncbi.nlm.nih.gov/pubmed/12665525).

Citations:
[54](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12665525/citedby/) Fields:

Bio Biochemistry

Translation:HumansCells

  97. Mitsiades N, Mitsiades CS, Richardson PG, McMullan C, Poulaki V, Fanourakis G, Schlossman R, Chauhan D, Munshi NC, Hideshima T, Richon VM, Marks PA, Anderson KC. Molecular sequelae of histone deacetylase inhibition in human malignant B cells. Blood. 2003 May 15; 101(10):4055-62. PMID: [12531799](//www.ncbi.nlm.nih.gov/pubmed/12531799).

Citations:
[100](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12531799/citedby/)
Fields:

Hem Hematology

Translation:HumansCells

  98. Joussen AM, Poulaki V, Mitsiades N, Stechschulte SU, Kirchhof B, Dartt DA, Fong GH, Rudge J, Wiegand SJ, Yancopoulos GD, Adamis AP. VEGF-dependent conjunctivalization of the corneal surface. Invest Ophthalmol Vis Sci. 2003 Jan; 44(1):117-23. PMID: [12506063](//www.ncbi.nlm.nih.gov/pubmed/12506063).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12506063/citedby/) Fields:

Oph Ophthalmology

Translation:AnimalsCells

  99. Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC. Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res. 2003 Jan 01; 63(1):18-21. PMID: [12517770](//www.ncbi.nlm.nih.gov/pubmed/12517770).

Citations:
[72](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12517770/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  100. Chauhan D, Li G, Auclair D, Hideshima T, Richardson P, Podar K, Mitsiades N, Mitsiades C, Li C, Kim RS, Munshi N, Chen LB, Wong W, Anderson KC. Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays. Blood. 2003 May 01; 101(9):3606-14. PMID: [12480690](//www.ncbi.nlm.nih.gov/pubmed/12480690).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12480690/citedby/) Fields:

Hem Hematology

Translation:Cells

  101. Podar K, Tai YT, Cole CE, Hideshima T, Sattler M, Hamblin A, Mitsiades N, Schlossman RL, Davies FE, Morgan GJ, Munshi NC, Chauhan D, Anderson KC. Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells. J Biol Chem. 2003 Feb 21; 278(8):5794-801. PMID: [12482878](//www.ncbi.nlm.nih.gov/pubmed/12482878).

Citations:
[36](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12482878/citedby/) Fields:

Bio Biochemistry

Translation:HumansCells

  102. Poulaki V, Mitsiades CS, Joussen AM, Lappas A, Kirchhof B, Mitsiades N. Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability. Am J Pathol. 2002 12; 161(6):2229-40. PMID: [12466137](//www.ncbi.nlm.nih.gov/pubmed/12466137); PMCID: [PMC1850903](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1850903).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12466137/citedby/) Fields:

Pat Pathology

Translation:HumansCells

  103. Joussen AM, Poulaki V, Mitsiades N, Cai WY, Suzuma I, Pak J, Ju ST, Rook SL, Esser P, Mitsiades CS, Kirchhof B, Adamis AP, Aiello LP. Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J. 2003 Jan; 17(1):76-8. PMID: [12475915](//www.ncbi.nlm.nih.gov/pubmed/12475915).

Citations:
[79](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12475915/citedby/) Fields:

Bio BiologyPhy Physiology

Translation:AnimalsCells

  104. Mitsiades CS, Mitsiades N, Poulaki V, Schlossman R, Akiyama M, Chauhan D, Hideshima T, Treon SP, Munshi NC, Richardson PG, Anderson KC. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene. 2002 Aug 22; 21(37):5673-83. PMID: [12173037](//www.ncbi.nlm.nih.gov/pubmed/12173037).

Citations:
[144](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12173037/citedby/)
Fields:

Mol Molecular BiologyNeo Neoplasms

Translation:HumansCells

  105. Poulaki V, Mitsiades CS, Kotoula V, Tseleni-Balafouta S, Ashkenazi A, Koutras DA, Mitsiades N. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. Am J Pathol. 2002 Aug; 161(2):643-54. PMID: [12163389](//www.ncbi.nlm.nih.gov/pubmed/12163389); PMCID: [PMC1850734](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1850734).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12163389/citedby/) Fields:

Pat Pathology

Translation:HumansCells

  106. Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC. Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Res. 2002 07 01; 62(13):3876-82. PMID: [12097303](//www.ncbi.nlm.nih.gov/pubmed/12097303).

Citations:
[53](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12097303/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  107. Gupta D, Podar K, Tai YT, Lin B, Hideshima T, Akiyama M, LeBlanc R, Catley L, Mitsiades N, Mitsiades C, Chauhan D, Munshi NC, Anderson KC. beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells. Exp Hematol. 2002 Jul; 30(7):711-20. PMID: [12135668](//www.ncbi.nlm.nih.gov/pubmed/12135668).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12135668/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  108. Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi NC, Treon SP, Anderson KC. Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications. Blood. 2002 Jun 15; 99(12):4525-30. PMID: [12036884](//www.ncbi.nlm.nih.gov/pubmed/12036884).

Citations:
[161](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12036884/citedby/)
Fields:

Hem Hematology

Translation:HumansCells

  109. Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi N, Treon SP, Anderson KC. Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. Blood. 2002 Jun 01; 99(11):4079-86. PMID: [12010810](//www.ncbi.nlm.nih.gov/pubmed/12010810).

Citations:
[90](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12010810/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  110. Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC, Treon SP. Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells. Blood. 2002 Mar 15; 99(6):2162-71. PMID: [11877293](//www.ncbi.nlm.nih.gov/pubmed/11877293).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11877293/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  111. Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T, Munshi N, Dang L, Castro A, Palombella V, Adams J, Anderson KC. NF-kappa B as a therapeutic target in multiple myeloma. J Biol Chem. 2002 May 10; 277(19):16639-47. PMID: [11872748](//www.ncbi.nlm.nih.gov/pubmed/11872748).

Citations:
[301](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11872748/citedby/)
Fields:

Bio Biochemistry

Translation:HumansCells

  112. Treon SP, Pilarski LM, Belch AR, Kelliher A, Preffer FI, Shima Y, Mitsiades CS, Mitsiades NS, Szczepek AJ, Ellman L, Harmon D, Grossbard ML, Anderson KC. CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications. J Immunother. 2002 Jan-Feb; 25(1):72-81. PMID: [11924912](//www.ncbi.nlm.nih.gov/pubmed/11924912).

Citations:
[30](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11924912/citedby/) Fields:

All Allergy and ImmunologyNeo NeoplasmsThe Therapeutics

Translation:HumansCellsCTClinical Trials

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 112 publications over 21 distinct years, with a maximum of
21 publications in
2003](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|21&cht=bvs&chd=t:0,0,0,0,0,0,0,0,62,100,29,38,33,33,29,29,10,10,10,19,19,10,29,5,19,10,14,14,14,0,0&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2002| 13  
2003| 21  
2004| 6  
2005| 8  
2006| 7  
2007| 7  
2008| 6  
2009| 6  
2010| 2  
2011| 2  
2012| 2  
2013| 4  
2014| 4  
2015| 2  
2016| 6  
2017| 1  
2018| 4  
2019| 2  
2020| 3  
2021| 3  
2022| 3  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

MITSIADES, M.D.'s Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (591)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Receptors, Androgen](https://profiles.viictr.org/profile/244337)
  * [Multiple Myeloma](https://profiles.viictr.org/profile/239730)
  * [Prostatic Neoplasms, Castration-Resistant](https://profiles.viictr.org/profile/27547115)
  * [Thyroid Neoplasms](https://profiles.viictr.org/profile/240451)
  * [Prostatic Neoplasms](https://profiles.viictr.org/profile/245090)

[Explore](https://profiles.viictr.org/profile/266621/198)

_

Co-Authors (42)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [FISKUS, WARREN C](https://profiles.viictr.org/profile/17440164)
  * [COARFA, CRISTIAN](https://profiles.viictr.org/profile/265668)
  * [MCGUIRE, SEAN ERIC](https://profiles.viictr.org/profile/12583840)
  * [O'MALLEY, BERT](https://profiles.viictr.org/profile/269511)
  * [ITTMANN, MICHAEL](https://profiles.viictr.org/profile/269566)

[Explore](https://profiles.viictr.org/profile/266621/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [ORLOWSKI, ROBERT](https://profiles.viictr.org/profile/12583884)
  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [LOGOTHETIS, CHRISTOPHER J](https://profiles.viictr.org/profile/12583246)
  * [MILLS, GORDON B](https://profiles.viictr.org/profile/12582930)
  * [CORTES, JORGE E](https://profiles.viictr.org/profile/12582539)

[Explore](https://profiles.viictr.org/profile/266621/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [BERNSTAM, ELMER](https://profiles.viictr.org/profile/30882399)
  * [BYUN, JINYOUNG](https://profiles.viictr.org/profile/28999157)
  * [HAN, YOUNGHUN](https://profiles.viictr.org/profile/28999010)
  * [OLUYOMI, ABIODUN](https://profiles.viictr.org/profile/21983659)
  * [THRIFT, AARON](https://profiles.viictr.org/profile/9909036)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [CHISOLM, OLETHIA](https://profiles.viictr.org/profile/267016)
  * [LIU, YANHONG](https://profiles.viictr.org/profile/268526)
  * [MINARD, CHARLES](https://profiles.viictr.org/profile/267444)
  * [SELLIN, JOSEPH](https://profiles.viictr.org/profile/266074)
  * [SPITZ, MARGARET](https://profiles.viictr.org/profile/266382)

_

